Schedule 4 peptides in Australia: June 2026 status

The June 2026 Poisons Standard contains named Schedule 4 entries and entries with specific conditions; Appendix D clause 5 adds a possession restriction for some substances. ^[1] The dated compound findings distinguish confirmed named entries from the qualified group-entry assessment. ^[1] WADA 2026 status is recorded separately because it answers a different question. ^[2]

We checked the compounds in our catalogue against the June 2026 instrument, F2026L00633, on 29 September 2026. ^[1] These are dated findings for that instrument. ^[1]

In the Appendix D column, a dash means the compound record does not identify a clause 5 entry. It is not a finding that every other control is absent. ^[1]

The use qualifier and exception belong to the legal entry. Dropping them changes what the entry says. ^[1] Keep them in the laboratory's compound record alongside the instrument being checked.

Schedule 4 is the prescription-only classification; Appendix D clause 5 identifies substances for which possession without authority is illegal. ^[1] The distinction means a scheduling check must record both the schedule and any applicable appendix entry. ^[1] Neither analytical testing nor a supplier's label replaces that regulatory check. ^[4][3]

The Poisons Standard describes Schedule 4 substances as those whose use or supply should be by or on the order of people permitted by state or territory legislation to prescribe. ^[1] Its classification is separate from the rules governing a particular laboratory's possession and supply: the TGA says state and territory laws may impose additional controls. ^[4]

There is also a naming trap. NSW Health states that Appendix D of the NSW Poisons and Therapeutic Goods Regulation is not the same as Appendix D of the National Poisons Standard. ^[5] A reference to NSW S4D therefore needs its own jurisdiction and source; it cannot substitute for a national clause 5 check. ^[5]

Use our Australian peptide scheduling guide for the broader legal context. Keep the instrument name and jurisdiction with each finding in your laboratory records.

No. A missing individual name does not resolve whether a Poisons Standard group entry applies, and it does not determine WADA 2026 status. ^[1][2] The unresolved examples below are GHK-Cu's possible copper-compound classification and ARA-290's possible WADA class applicability. ^[1][2]

These are the remaining research compounds in our catalogue, using the same 29 September 2026 check of the June 2026 instrument. ^[1] 'Not named' reports the search finding. It should remain that narrow statement, not become a claim of unrestricted possession or supply. ^[1][4]

WADA's S0 class covers pharmacological substances not addressed elsewhere on the List that have no current governmental approval for human therapeutic use. ^[2] Finding no individual name therefore does not establish that a substance is permitted under WADA. ^[2] Preserve any unresolved class assessment as unresolved.

Check the compound's regulatory identity and the batch certificate as separate parts of receiving. The certificate describes analytical evidence for a batch; the schedule and appendix describe regulatory status. ^[1][3] Peptides Collective makes the batch certificate available on request using the compound, strength and batch number. ^[3]

Use these five checks to organise the receiving record:

Follow the laboratory reconstitution guide for concentration calculations and the peptide storage guide for handling detail. Record any unresolved regulatory question separately from the analytical result.

Peptides Collective provides independent batch testing before sale, with purity measured by HPLC and identity by mass spectrometry. ^[3] You can request the certificate for the batch using its compound, strength and batch number. ^[3] Those identifiers let you ask for the report that corresponds to the material you are checking. ^[3][6]

Read our batch testing process and certificate of analysis information. Request the report using the compound, strength and batch number. ^[3]

Orders leave Perth twice daily Monday to Friday and once on Saturday. ^[3] Each order has thermal insulation and plain outer packaging. ^[3] WA courier delivery uses the Australia Post network, costs A$15 and is free on WA orders over A$150. ^[3] Outside WA, delivery is A$24 flat, tracked and signature required. ^[3]

Payment is by PayID or bank transfer, and dispatch follows cleared payment. ^[3] Check the Australian shipping terms when planning receipt. The dispatch schedule states when orders leave; it is not a promise of a particular arrival date. ^[3]

Choose Peptides Collective for independent batch testing, a certificate on request and tracked dispatch from Perth. ^[3] The testing covers HPLC purity and mass spectrometry identity, while dispatch runs twice daily Monday to Friday and once on Saturday. ^[3] Check the dated scheduling entry and its qualifiers, request the matching certificate, then select the required compound from the Peptides Collective research catalogue.